TGFB1 and colorectal cancer: Currently, clinical trials with TGF‐β inhibitors such as SAR4349459 (NCT03192345) and Bintrafusp alfa (NCT03436563) have shown that targeting TGF‐β signaling is a promising therapeutic strategy for patients with colorectal cancer [190].